Related Experiment Video
Updated: Apr 15, 2026

09:38
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.5K
Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study
Niki Karachaliou1, Jia Wei2, Ana Daniela Marques3
1Breakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute, Barcelona, Spain ;
Translational Lung Cancer Research
|March 26, 2015
Abstract
No abstract available in PubMed .
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.9K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.3K